Opko Health, Inc.

OPKO Health, Inc. is a diversified healthcare company that seeks to establish industry-leading positions in large, rapidly growing markets.  Our diagnostics business includes Bio-Reference Laboratories, the nation’s third-largest clinical laboratory with a core genetic testing business and a 420-person salesforce to drive growth and leverage new products, including the 4Kscore® prostate cancer test and the Claros®1 in-office immunoassay platform.

 

Bank Name Opko Health, Inc.
Stock Exchange NASDAQ
Symbol OPK
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman Dr. Philip Frost
CEO
Employees 6030
Website www.opko.com
Registered Year 1991

 

UpdateContent
UpdateContent
UpdateContent